Cost/effectiveness comparison of the vaccine campaign and reduction of sick leave, after vaccination against influenza among the Clermont-Ferrand University Hospital staff;Comparaison coût/bénéfice de la campagne vaccinale et de la réduction de l'absentéisme, après vaccination contre la grippe du personnel du CHU de Clermont-Ferrand

Medecine et Maladies Infectieuses

Volumn 38, Issue 11, 2008, Pages 567-573

  Dutheil, F ^a,b   Delaire, P ^b   Boudet, G ^b   Rouffiac, K ^a   Djeriri, K ^b   Souweine, B ^a   Chamoux, A ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Cost benefit; Influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ABSENTEEISM; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; HOSPITAL PERSONNEL; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MEDICAL LEAVE;

COST-BENEFIT ANALYSIS; FRANCE; HUMANS; INFLUENZA VACCINES; MEDICAL STAFF, HOSPITAL; PERSONNEL, HOSPITAL; SICK LEAVE;

EID: 56549115500     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2008.09.019     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention (CDC). Interventions to increase influenza vaccination of health-care workers - California and Minnesota. MMWR Morb Mortal Wkly Rep. 2005;54(8):196-9.
2. Carman W.F., Elder A.G., Wallace L.A., McAulay K., Walker A., Murray G.D., et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 355 9198 (2000) 93-97
3. o 2005-1579 du 19 décembre 2005 de financement de la sécurité sociale pour 2006, article 62 et article 63 du Journal officiel du 20 décembre 2005.
4. Enquête Sofres/Groupe d'étude et d'information de la grippe : la couverture vaccinale « grippe » des français, saison grippe 2002-2003.
5. Chamoux A., Denis-Porret M., Rouffiac K., Baud O., Millot-Theis B., and Souweine B. Impact study of an active antiflu vaccination programme on the Clermont-Ferrand teaching hospital staff. Med Mal Infect 36 3 (2006) 144-150
6. Rothberg M.B., and Rose D.N. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Am J Med 118 1 (2005) 68-77
7. Akazawa M., Sindelar J.L., and Paltiel A.D. Economic costs of influenza-related work absenteeism. Value Health 6 2 (2003) 107-115
8. Nichol K.L., Mallon K.P., and Mendelman P.M. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine 21 17-18 (2003) 2207-2217
9. de Juanes J.R., Cisterna R., Sanz J., Magaz S., and Badia X. Efficiency of influenza vaccination in the working population in Spain. Gac Sanit 20 2 (2006) 101-107
10. Nichol K.L. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 161 5 (2001) 749-759
11. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., Cox N.J., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 284 13 (2000) 1655-1663
12. Campbell D.S., and Rumley M.H. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 39 5 (1997) 408-414
13. Cella M.T., Corona G., Tuccillo E., and Franco G. Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting. Med Lav 96 6 (2005) 483-489
14. Chan A.L., Shie H.J., Lee Y.J., and Lin S.J. The evaluation of free influenza vaccination in health care workers in a medical center in Taiwan. Pharm World Sci 30 1 (2008) 39-43
15. Rizzuto E., Prete A.M., Virtuani L., and Pompa M.G. Effectiveness of influenza vaccination: a survey within the Italian Ministry of Health personnel. Vaccine 24 44-46 (2006) 6612-6614
16. Lee P.Y., Matchar D.B., Clements D.A., Huber J., Hamilton J.D., and Peterson E.D. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med 137 4 (2002) 225-231